Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Madeleine Duvic, Ann G. Martin, Elise A. Olsen, David P. Fivenson & H. Miles Prince. (2013) Efficacy and safety of denileukin diftitox retreatment in patients with relapsed cutaneous T-cell lymphoma. Leukemia & Lymphoma 54:3, pages 514-519.
Read now
Read now
Chunlei Zhang & Madeleine Duvic. (2010) Vorinostat for the treatment of cutaneous T-cell lymphoma. Expert Review of Dermatology 5:4, pages 393-401.
Read now
Read now
Michael Robert Humphreys, Maria Cino, Ian Quirt, David Barth & Vishal Kukreti. (2008) Long-term survival in two patients with hepatosplenic T cell lymphoma treated with interferon-alpha. Leukemia & Lymphoma 49:7, pages 1420-1423.
Read now
Read now
Madeleine Duvic & Jenny Vu. (2007) Update on the treatment of cutaneous T-cell lymphoma (CTCL): Focus on vorinostat. Biologics: Targets and Therapy 1:4, pages 377-392.
Read now
Read now
Madeleine Duvic & Jenny Vu. (2007) Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma. Expert Opinion on Investigational Drugs 16:7, pages 1111-1120.
Read now
Read now
Jörg Vollmer. (2005) Progress in drug development of immunostimulatory CpG oligodeoxynucleotide ligands for TLR9. Expert Opinion on Biological Therapy 5:5, pages 673-682.
Read now
Read now
John W Eklund & Timothy M Kuzel. (2005) Denileukin diftitox: a concise clinical review. Expert Review of Anticancer Therapy 5:1, pages 33-38.
Read now
Read now
Articles from other publishers (23)
Joan Guitart. (2023) Dupilumab, Atopic Dermatitis, and Mycosis Fungoides—New Insights on an Evolving Story. JAMA Dermatology 159:11, pages 1177.
Crossref
Crossref
Jamal Knaneh, Emmilia Hodak, Shlomit Fedida-Metula, Avishay Edri, Rachel Eren, Yael Yoffe, Iris Amitay-Laish, Hadas Prag Naveh, Ido Lubin, Angel Porgador & Lilach Moyal. (2023) mAb14, a Monoclonal Antibody against Cell Surface PCNA: A Potential Tool for Sezary Syndrome Diagnosis and Targeted Immunotherapy. Cancers 15:17, pages 4421.
Crossref
Crossref
Natalia Rendón‐Serna, Luis A. Correa‐Londoño, Margarita M. Velásquez‐Lopera & Maria Bermudez‐Muñoz. (2021) Cell signaling in cutaneous T‐cell lymphoma microenvironment: promising targets for molecular‐specific treatment. International Journal of Dermatology 60:12, pages 1462-1480.
Crossref
Crossref
Kazuyasu Fujii. (2018) New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma. Frontiers in Oncology 8.
Crossref
Crossref
Anne Schroeder, Uwe Warnken, Daniel Röth, Karel D. Klika, Diana Vobis, Andrea Barnert, Fatmire Bujupi, Tina Oberacker, Martina Schnölzer, Jan P. Nicolay, Peter H. Krammer & Karsten Gülow. (2017) Targeting Thioredoxin-1 by dimethyl fumarate induces ripoptosome-mediated cell death. Scientific Reports 7:1.
Crossref
Crossref
Sadanori Furudate, Taku Fujimura, Aya Kakizaki, Takanori Hidaka, Masayuki Asano & Setsuya Aiba. (2016) Tumor-associated M2 macrophages in mycosis fungoides acquire immunomodulatory function by interferon alpha and interferon gamma. Journal of Dermatological Science 83:3, pages 182-189.
Crossref
Crossref
Robert E. Hutchison & Katherine I. Schexneider. 2011. Henry's Clinical Diagnosis and Management by Laboratory Methods. Henry's Clinical Diagnosis and Management by Laboratory Methods
601
655
.
Jacqueline M. Junkins-Hopkins. (2009) Immunomodulatory therapy of cutaneous T-cell lymphoma: A multimodality approach in advanced disease. Journal of the American Academy of Dermatology 61:6, pages 1056-1058.
Crossref
Crossref
D.S. Mestel, M. Beyer, M. Steinhoff & W. Sterry. (2009) Treatment of Cutaneous Lymphomas: Today and Tomorrow. Actas Dermo-Sifiliográficas 100, pages 18-32.
Crossref
Crossref
Renato Soriani Paschoal, Renata Nahas Cardilli, Darlene Arruda, Belinda Pinto Simões & Cacilda da Silva Souza. (2009) Linfoma subcutâneo de células T paniculite-símile. Anais Brasileiros de Dermatologia 84:4, pages 415-419.
Crossref
Crossref
Andreas Lange, Claudia Kistler, Tanja B. Jutzi, Alexandr V. Bazhin, Claus Detlev Klemke, Dirk Schadendorf & Stefan B. Eichmüller. (2009) Detergent fractionation with subsequent subtractive suppression hybridization as a tool for identifying genes coding for plasma membrane proteins. Experimental Dermatology 18:6, pages 527-535.
Crossref
Crossref
N. Nieto-Rementería, G. Pérez-Yarza, M.D. Boyano, A. Apraiz, R. Izu, J.L. Díaz-Pérez & A. Asumendi. (2009) Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma. British Journal of Dermatology 160:3, pages 519-526.
Crossref
Crossref
Ella Ares. (2008) An uncommon skin condition illustrates the need for caution when prescribing for friends. Journal of the American Academy of Nurse Practitioners 20:8, pages 389-395.
Crossref
Crossref
R F Duarte, N Schmitz, O Servitje & A Sureda. (2008) Haematopoietic stem cell transplantation for patients with primary cutaneous T-cell lymphoma. Bone Marrow Transplantation 41:7, pages 597-604.
Crossref
Crossref
Taku Fujimura, Ryuhei Okuyama, Akiko Watabe, Akira Hashimoto, Hachiro Tagami & Setsuya Aiba. (2007) Interferon-? is effective for CD4+, CCR4? mycosis fungoides. International Journal of Dermatology 46:4, pages 435-438.
Crossref
Crossref
G Yang, M A Thompson, S J Brandt & S W Hiebert. (2006) Histone deacetylase inhibitors induce the degradation of the t(8;21) fusion oncoprotein. Oncogene 26:1, pages 91-101.
Crossref
Crossref
Giovanni Luigi Capella. (2007) Selective costimulation modulators of T cells: A potential treatment for mycosis fungoides and other SALT-proliferating diseases. Medical Hypotheses 68:2, pages 452.
Crossref
Crossref
A. Süß, T. Wetzig, M. Sticherling, A. Tannapfel & J. C. Simon. (2006) Mycosis fungoides und chronisch lymphatische B-Zell-LeukämieMycosis fungoides and B-cell chronic lymphocytic leukemia. Der Hautarzt 57:10, pages 888-892.
Crossref
Crossref
Cynthia M. Magro, Kay H. Seilstad, Pierluigi Porcu & Carl D. Morrison. (2006)
Primary CD20+CD10+CD8+ T-Cell Lymphoma of the Skin With Dual
IgH
and
TCRβ
Gene Rearrangement
. American Journal of Clinical Pathology 126:1, pages 14-22.
Crossref
Crossref
Che-Leung Law, Kristine A. Gordon, Brian E. Toki, Andrew K. Yamane, Michelle A. Hering, Charles G. Cerveny, Joseph M. Petroziello, Maureen C. Ryan, Leia Smith, Ronald Simon, Guido Sauter, Ezogelin Oflazoglu, Svetlana O. Doronina, Damon L. Meyer, Joseph A. Francisco, Paul Carter, Peter D. Senter, John A. Copland, Christopher G. Wood & Alan F. Wahl. (2006) Lymphocyte Activation Antigen CD70 Expressed by Renal Cell Carcinoma Is a Potential Therapeutic Target for Anti-CD70 Antibody-Drug Conjugates. Cancer Research 66:4, pages 2328-2337.
Crossref
Crossref
Theo Dingermann & Ilse Zündorf. (2006) Macromolecular Immunosuppressants. Biotechnology Journal 1:1, pages 47-57.
Crossref
Crossref
Ilse Zündorf, Angelika M. Vollmar & Theo Dingermann. (2005) Makromolekulare Immunsuppressiva: Proteinogene Wirkstoffe. Pharmazie in unserer Zeit 34:4, pages 283-296.
Crossref
Crossref
Tracey J. Mitchell & Susan John. (2005) Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas. Immunology 114:3, pages 301-312.
Crossref
Crossref